| Abstract: |
| 放射性碘主要用于
分化型甲状腺癌(differentiated thyroid cancer, DTC)的治疗。18F-FDG PET/CT作为有效的诊断工具，是放射性碘扫描的有益补充。PET/MR是一种新型的显像技术，可为DTC患者诊断、治疗或病情评估提供帮助。本文主要综述了目前几种可用放射性药物(包括18F-FDG、124I、18F-TFB和68Ga-PSMA在内的多种示踪剂)的物理、生物学特性及其与最先进技术相结合对于DTC患者的诊断、治疗和随访的作用。 |
| Key words: 分化型甲状腺癌 PET/MR 示踪剂 |
| 通信作者: |
| DOI：10.12289/j.issn.2097-4345.24091 |
| Received:March 04, 2024 |
| AdoptTime:June 01, 2024 |
| Fund:上海市浦东新区卫生系统学科建设重点学科(PWZxk2022-12) |
|
| Research progress of PET/MR in differentiated thyroid cancerLUO Yingying, WANG Haiyan, ZHAO Jun |
| LUO Yingying,WANG Haiyan,ZHAO Jun |
| (Department of Nuclear Medicine, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai 200120, China) |
| Abstract: |
| Radioactive iodine is used mostly in treating
differentiated thyroid cancer(DTC) with a therapeutic intent, while PET/CT with 18F-FDG emerges as a useful tool in the diagnostic management and complements the use of radioactive iodine. The PET/MR imaging may provide a new imaging technique for the diagnosis, treatment or disease assessment of the DTC. This article mainly reviews the physical and biological characteristics of several currently available radiopharmaceuticals(including various tracers such as 18F-FDG, 124I, 18F-TFB and 68Ga-PSMA), and their combination with the most advanced technology provides new possibilities for the diagnosis, treatment and follow-up of DTC patients. |
| Key words: differentiated thyroid cancer PET/MR tracer |
